Tumor angiogenesis induced by granulocyte chemotactic protein-2 as a countercurrent principle

American Journal of Pathology

Volumn 159, Issue 4, 2001, Pages 1405-1414

  Van Coillie, Els ^a   Van Aelst, Ilse ^a   Wuyts, Anja ^a   Vercauteren, Roeland ^a   Devos, Rita ^b   De Wolf Peeters, Chris ^b   Van Damme, Jo ^a   Opdenakker, Ghislain ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; CHEMOTACTIC PEPTIDE; GELATINASE B; GRANULOCYTE CHEMOTACTIC PROTEIN 2; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE TECHNOLOGY; GENE TRANSFER; GROWTH INHIBITION; LEUKOCYTE ACTIVATION; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; TUMOR GROWTH; TUMOR VASCULARIZATION;

EID: 0034785492     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)62527-8     Document Type: Article

References (34)

1. Regulation of the macrophage content of neoplasms by chemoattractants
2. Identification of monocyte chemotactic activity produced by malignant cells
3. A chemoattractant expressed in human sarcoma cells (tumor-derived chemotactic factor, TDCF) is identical to monocyte chemoattractant protein-1/monocyte chemotactic and activating factor (MCP-1/MCAF)
4. 2-terminal sequence-characterized human monokine possessing neutrophil chemotactic, skin-reactive, and granulocytosis-promoting activity
5. Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family
6. The origin and function of tumor-associated macrophages
7. Chemotactic factors, passive invasion and metastasis of cancer cells
8. Interleukin-8 as a macrophage-derived mediator of angiogenesis
9. Chemokines: A new classification system and their role in immunity
10. Platelet factor 4 binds to interleukin 8 receptors and activates neutrophils when its N terminus is modified with Glu-Leu-Arg
11. Scanning mutagenesis of interleukin-8 identifies a cluster of residues required for receptor binding
12. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines
13. The role of CXC chemokines as regulators of angiogenesis
14. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis
15. Identification of a novel granulocyte chemotactic protein (GCP-2) from human tumor cells. In vitro and in vivo comparison with natural forms of GRO, IP-10, and IL-8
16. Identification of mouse granulocyte chemotactic protein-2 from fibroblasts and epithelial cells. Functional comparison with natural KC and macrophage inflammatory protein-2
17. Glucocorticoid-attenuated response genes encode intercellular mediators, including a new C-X-C chemokine
18. Multi-subunit proteins on the surface of filamentous phage: Methodologies for displaying antibody (Fab) heavy and light chains
19. Functional comparison of two human monocyte chemotactic protein-2 isoforms, role of the aminoterminal pyroglutamic acid and processing by CD26/dipeptidyl peptidase IV
20. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
21. Human hepatoma cells produce an 85 kDa gelatinase regulated by phorbol 12-myristate 13-acetate
22. 2- and COOH-terminal truncations of murine granulocyte chemotactic protein-2 augment the in vitro and in vivo neutrophil chemotactic potency
23. CXC chemokines in angiogenesis
24. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer
25. Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer
26. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact
27. MMP-9 supplied by bone-marrow-derived cells contributes to skin carcinogenesis
28. The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma
29. Inflammation and cancer: Back to Virchow?
30. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
31. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
32. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics
33. Induction of tumor angiogenesis by VEGF-C promotes breast cancer metastasis